Simulations Plus to Participate in the Morgan Stanley 3rd Annual Life Sciences AI Summit

• June 20, 2024
• Press Release

Simulations Plus, Inc. (Nasdaq: SLP) ("Simulations Plus"), a leading provider of biosimulation, simulation-enabled performance and intelligence solutions, and medical communications for the biopharma industry, today announced that Shawn O'Connor, chief executive officer, will participate in the Morgan Stanley 3^rd Annual Life Sciences AI Summit on Wednesday, June 26, 2024, at Morgan Stanley's headquarters in New York City. Mr. O'Connor will join a panel discussion entitled "Transforming Research - Optimizing from Lab to Trial" at 2:10 p.m. EDT, and he will host one-on-one meetings with investors following the panel discussion.

This event will feature sessions focused on the AI-driven paradigm shift unfolding across the biopharma value chain and discussions with some of the most influential companies operating at the intersection of life sciences and technology innovation. For more information about the conference, please visit the Morgan Stanley conference website.